secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001213900-23-075549
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals to present at H.C. Wainwright conference; no material updates disclosed
--------------------------------------------------------------------------------

- Company will present at H.C. Wainwright 25th Annual Global Investment Conference Sept 11-13, 2023.
- Investor presentation furnished as Exhibit 99.1 contains no new financial or operational data.
- No earnings, guidance, or pipeline milestones announced in this filing.
- Filing is procedural under Regulation FD; presentation includes standard forward-looking statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390023075549/0001213900-23-075549-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390023075549/ea184974-8k_adialpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-075549

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer